Pemetrexed-induced eccrine squamous syringometaplasia manifesting as pseudocellulitis (in a patient with non–small cell lung cancer)


CAR: cutaneous adverse reaction INTRODUCTION Pemetrexed (Alimta, Eli Lily and Company, Indianapolis, Indiana) is a multitargeted antifolate drug approved as a single agent or in combination with cisplatin for the treatment of some malignancies including advanced and metastatic nonsquamous nonesmall cell lung cancer and malignant pleural mesothelioma… (More)
DOI: 10.1016/j.jdcr.2016.11.001


2 Figures and Tables